mitoxantrone has been researched along with Tuberculosis, Drug-Resistant in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A | 1 |
| Pal, SK | 1 |
| Pandey, D | 1 |
| Fakir, NA | 1 |
| Rathod, S | 1 |
| Sinha, D | 1 |
| SivaKumar, S | 1 |
| Sinha, P | 1 |
| Periera, M | 1 |
| Balgam, S | 1 |
| Sekar, G | 1 |
| UmaDevi, KR | 1 |
| Anupurba, S | 1 |
| Nema, V | 1 |
1 other study available for mitoxantrone and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
Topics: Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambut | 2017 |